Albemarle’s $1.4 Billion Registered Common Stock Offering
February 24, 2021
Cravath represented the underwriters in connection with the $1.4 billion registered common stock offering of Albemarle Corporation, a leading global developer, manufacturer and marketer of highly engineered specialty chemicals across end markets including petroleum refining, consumer electronics, plastics/packaging, construction, automotive, lubricants, pharmaceuticals, crop protection, food safety and custom chemistry services. The shares were listed on the New York Stock Exchange. The transaction closed on February 8, 2021.
The Cravath team included partners William V. Fogg and Michael E. Mariani and associates Steven Y. Li and Zoe E. Egelman on capital markets matters, and partner Christopher K. Fargo and associates Rory M. Minnis and Carlos Nicholas Obando on tax matters.
Related Practices & Industries
People
- Photo
-
-
J.D., 1991, Columbia Law SchoolHarlan Fiske Stone Scholar
-
A.B., 1988, Brown Universitymagna cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 2009, Columbia Law SchoolHarlan Fiske Stone Scholar
-
M.B.A., 2009, Columbia University
-
B.A., 2004, Tufts UniversityPhi Beta Kappa, summa cum laude
- New York
Education
Admitted In
- Photo
-
-
J.D., 2006, Columbia Law SchoolHarlan Fiske Stone; Michael Lynne Scholar
-
B.A., 2003, Boston CollegeHonors Program, cum laude
- New York
Education
Admitted In
Related News & Insights
Deals & Cases
March 19, 2024
Albemarle’s $2.3 Billion Public Offering of Mandatory Convertible Preferred Stock
Cravath represented Albemarle Corporation in connection with its $2.3 billion public offering of depositary shares, each representing a 1/20th interest in a share of Series A Mandatory Convertible Preferred Stock of Albemarle, at a public offering price of $50 per share. Albemarle leads the world in transforming essential resources into critical ingredients for mobility, energy, connectivity and health. The transaction closed on March 8, 2024.
